azacitidine has been researched along with Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, X; Hu, Z | 1 |
| Deng, X; Hu, Z; Li, X; Liu, Z; Zhou, Y | 1 |
| Malik, A; Misbah, S; Spaccavento, C; Yudelman, I | 1 |
3 other study(ies) available for azacitidine and Hearing Loss
| Article | Year |
|---|---|
Generation of Cochlear Hair Cells from Sox2 Positive Supporting Cells via DNA Demethylation.
Topics: Animals; Azacitidine; DNA Methylation; Female; Furosemide; Hair Cells, Auditory; Hearing Loss; Kanamycin; Male; Mice; Mice, Transgenic; SOXB1 Transcription Factors | 2020 |
Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model.
Topics: Animals; Azacitidine; Cochlea; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Ear, Inner; Enzyme Inhibitors; Furosemide; Hair Cells, Auditory, Inner; Hearing Loss; Humans; Kanamycin; Mice; Regeneration | 2019 |
Is there an association between 5-azacitidine and ototoxicity?
Topics: Antimetabolites, Antineoplastic; Azacitidine; Female; Hearing Loss; Humans; Middle Aged; Myelodysplastic Syndromes | 2010 |